Ole Kirk

Ole Kirk

Postgraduate Clinical Associate Professor, Clinical Associate Professor

Member of:

  • Internal medicine: infection medicine


  1. 2013
  2. Published

    Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events

    Monforte, A. D., Reiss, P., Ryom, Lene, El-Sadr, W., Dabis, F., De Wit, S., Worm, S. W., Law, M. G., Weber, R., Kirk, Ole, Pradier, C., Phillips, A. N., Lundgren, Jens & Sabin, C. A., 28 Jan 2013, In: AIDS (London, England). 27, 3, p. 407-15 9 p.

    Research output: Contribution to journalJournal articleResearch

  3. Published

    Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

    Worm, S. W., Bower, M., Reiss, P., Bonnet, F., Law, M., Fätkenheuer, G., d'Arminio Monforte, A., Abrams, D. I., Grulich, A., Fontas, E., Kirk, Ole, Furrer, H., De Wit, S., Phillips, A., Lundgren, Jens, Sabin, C. A. & D:A:D Study Group, D. S. G., 2013, In: B M C Infectious Diseases. 13, p. 471

    Research output: Contribution to journalJournal articleResearch

  4. Published

    Risk factors and outcomes for late presentation for HIV-positive persons in europe: results from the collaboration of observational HIV epidemiological research europe study (COHERE)

    Mocroft, A., Lundgren, J. D., Sabin, M. L., Monforte, A. DA., Brockmeyer, N., Casabona, J., Castagna, A., Costagliola, D., Dabis, F., De Wit, S., Fätkenheuer, G., Furrer, H., Johnson, A., Lazanas, M. K., Leport, C., Moreno, S., Obel, N., Post, F. A., Reekie, J., Reiss, P. & 12 others, Sabin, C., Skaletz-Rorowski, A., Suarez-Lozano, I., Torti, C., Warszawski, J., Zangerle, R., Fabre-Colin, C., Kjaer, J., Chene, G., Grarup, J., Kirk, Ole & Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord, C. O. O. H. E. R. E. (. S. I. E., 2013, In: P L o S Medicine (Online). 10, 9, p. e1001510

    Research output: Contribution to journalJournal articleResearch

  5. Published

    The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era

    Mocroft, A., Furrer, H. J., Miro, J. M., Reiss, P., Mussini, C., Kirk, O., Abgrall, S., Ayayi, S., Bartmeyer, B., Braun, D., Castagna, A., d'Arminio Monforte, A., Gazzard, B., Gutierrez, F., Hurtado, I., Jansen, K., Meyer, L., Muñoz, P., Obel, N., Soler-Palacin, P. & 15 others, Papadopoulos, A., Raffi, F., Ramos, J. T., Rockstroh, J. K., Salmon, D., Torti, C., Warszawski, J., de Wit, S., Zangerle, R., Fabre-Colin, C., Kjaer, J., Chene, G., Grarup, J., Lundgren, Jens & EuroCOORD, O. I. W. G. O. B. O. T. C. O. O. H. E. R. E. (. S. I., 2013, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 57, 7, p. 1038-1047 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 917608